
These results suggest the distinct roles of the helix-based cytoskeletal proteins in the nucleus.Ĭytoskeleton EGFP Keratin LMB Monoclonal antibody NES NLS NPC Nuclear matrix Nuclear scaffold Nuclear transport enhanced-GFP leptomycin B nuclear export signal nuclear localization signal nuclear pore complex.Ĭopyright © 2013 Elsevier Inc. (very often murine) parental antibody to the scaffold of a human antibody. An antibody is a Y shaped protein that is produced in the immune system and is designed to target a specific protein or molecule. Nuclear keratins do not take an obvious filamentous structure, as was revealed by non-filamentous cytoplasmic keratin-specific monoclonal antibody. Antibodies in complex with haptens, proteins, or peptides show distinctive. Each antibody consists of four polypeptides two heavy chains and two light chains. Their nuclear shuttling properties were verified by the apparent nuclear accumulations under inhibition of CRM1-dependent nuclear export. Antibodies are immune system-related proteins called immunoglobulins. Interestingly, sets of antibodies distinguished distinct subcellular localization of a single isoform of certain cytoskeletal proteins distinct molecular forms of keratin and actinin were found in the nucleus. Early examples were the Affibody, Monobody (Adnectin), and Anticalin proteins, which were derived from fragments of streptococcal protein A, from the tenth type III domain of human fibronectin, and from natural lipocalin proteins. Many helix-based cytoskeletal proteins were identified as antigens, suggesting their dynamic contribution to nuclear architecture and function. The concept of engineering robust protein scaffolds for novel binding functions emerged 20 years ago, one decade after the advent of recombinant antibody technology.


The amino acid sequence in the tips of the 'Y' varies greatly among different antibodies. In the first constrained hallucination approach, we carry out gradient descent in sequence space to optimize a loss function which simultaneously rewards recapitulation of the desired functional site and the ideality of the surrounding scaffold, supplemented with problem-specific interaction terms, to design candidate immunogens. Each antibody consists of four polypeptides two heavy chains and two light chains joined to form a 'Y' shaped molecule. To uncover the molecular composition and dynamics of the functional scaffold for the nucleus, three fractions of biochemically-stable nuclear protein complexes were extracted and used as immunogens to produce a variety of monoclonal antibodies. Antibodies are immune system-related proteins called immunoglobulins.
